Thalidomide is an inhibitor of angiogenesis. RJ D'Amato, MS Loughnan, E Flynn, J Folkman Proceedings of the National Academy of Sciences 91 (9), 4082-4085, 1994 | 3323 | 1994 |
Oxygen-induced retinopathy in the mouse. LE Smith, E Wesolowski, A McLellan, SK Kostyk, R D'amato, R Sullivan, ... Investigative ophthalmology & visual science 35 (1), 101-111, 1994 | 2097 | 1994 |
Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective … JA Javitch, RJ D'Amato, SM Strittmatter, SH Snyder Proceedings of the National Academy of Sciences 82 (7), 2173-2177, 1985 | 1593 | 1985 |
Inhibition of angiogenesis in vivo by interleukin 12 EE Voest, BM Kenyon, MS O'reilly, G Truitt, RJ D'amato, J Folkman JNCI: Journal of the National Cancer Institute 87 (8), 581-586, 1995 | 934 | 1995 |
Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol N Klauber, S Parangi, E Flynn, E Hamel, RJ D'Amato Cancer research 57 (1), 81-86, 1997 | 800 | 1997 |
Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization BM KENYON, F Browne, RJ D'amato Experimental eye research 64 (6), 971-978, 1997 | 632 | 1997 |
A model of angiogenesis in the mouse cornea. BM Kenyon, EE Voest, CC Chen, E Flynn, J Folkman, RJ D'Amato Investigative ophthalmology & visual science 37 (8), 1625-1632, 1996 | 555 | 1996 |
2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. RJ D'Amato, CM Lin, E Flynn, J Folkman, E Hamel Proceedings of the National Academy of Sciences 91 (9), 3964-3968, 1994 | 536 | 1994 |
Involvement of platelets in tumour angiogenesis? HM Pinedo, HMW Verheul, RJ D'amato, J Folkman The Lancet 352 (9142), 1775-1777, 1998 | 475 | 1998 |
Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: implications for cellular surrogate marker analysis of antiangiogenesis Y Shaked, F Bertolini, S Man, MS Rogers, D Cervi, T Foutz, K Rawn, ... Cancer cell 7 (1), 101-111, 2005 | 463 | 2005 |
MPTP: A neurotoxin relevant to the pathophysiology of Parkinson's disease: The 1985 George C. Cotzias Lecture SH Snyder, RJ D'Amato Neurology 36 (2), 250-250, 1986 | 387 | 1986 |
Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin RJ D'Amato, ZP Lipman, SH Snyder Science 231 (4741), 987-989, 1986 | 376 | 1986 |
Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer CJ Kuo, F Farnebo, EY Yu, R Christofferson, RA Swearingen, R Carter, ... Proceedings of the National Academy of Sciences 98 (8), 4605-4610, 2001 | 371 | 2001 |
Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model O Kisker, CM Becker, D Prox, M Fannon, R D’Amato, E Flynn, WE Fogler, ... Cancer Research 61 (20), 7669-7674, 2001 | 362 | 2001 |
Exogenous control of mammalian gene expression through modulation of RNA self-cleavage L Yen, J Svendsen, JS Lee, JT Gray, M Magnier, T Baba, RJ D'Amato, ... Nature 431 (7007), 471-476, 2004 | 341 | 2004 |
Aminergic systems in Alzheimer's disease and Parkinson's disease RJ D'Amato, RM Zweig, PJ Whitehouse, GL Wenk, HS Singer, R Mayeux, ... Annals of Neurology: Official Journal of the American Neurological …, 1987 | 329 | 1987 |
Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. RJ D'Amato, ME Blue, BL Largent, DR Lynch, DJ Ledbetter, ME Molliver, ... Proceedings of the National Academy of Sciences 84 (12), 4322-4326, 1987 | 328 | 1987 |
Selective labeling of serotonin uptake sites in rat brain by [3H] citalopram contrasted to labeling of multiple sites by [3H] imipramine. RJ D'Amato, BL Largent, AM Snowman, SH Snyder Journal of Pharmacology and Experimental Therapeutics 242 (1), 364-371, 1987 | 318 | 1987 |
Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium C Schwesinger, C Yee, RM Rohan, AM Joussen, A Fernandez, TN Meyer, ... The American journal of pathology 158 (3), 1161-1172, 2001 | 315 | 2001 |
Methods and compositions for inhibition of angiogenesis R D'amato US Patent 5,712,291, 1998 | 308 | 1998 |